People · Operator
Named in public records as an officer, director or promoter · active 2013–2026 · Biotechnology, Other Technology, Medical Devices, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arbor Biotechnologies, Inc. | — | Biotechnology | Series D+ | $230.6M | $5.7B | 2021 |
| Flywheel Exchange Inc. | — | Other Technology | Series C | $144.1M | $97.9M | 2025 |
| ACTIV Surgical, Inc. | — | Medical Devices | Series C | $86.6M | $240.1M | 2020 |
| vTv Therapeutics Inc. | — | Pharmaceuticals | Series C | $80.5M | $502.3M | 2017 |
| LevitasBio, Inc. | — | Other Technology | Series B | $73.8M | $96.3M | 2022 |
| Quanterix Corp | — | Other Technology | Series C | $71.8M | $194.1M | 2013 |
| Mercy BioAnalytics, Inc. | — | Biotechnology | Series B | $27.3M | $920.0M | 2020 |
| LumaCyte, Inc. | — | Biotechnology | Series A | $21.0M | $79.6M | 2022 |
| Kumanu, Inc. | — | Other Technology | Series A | $13.3M | $2.2M | 2017 |
| BlueWhale Bio, Inc. | — | Biotechnology | Series A | $5.0M | $14.2M | 2025 |
| Everest Biolabs, Inc. | — | Biotechnology | Series A | $4.3M | $10.3M | 2026 |
| Perfect Air Holdco LLC | — | Other | Seed | $1.9M | $19.8M | 2022 |
Paul Meister at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Meister on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Walt | 3 | 6 |
| Keith Crandell | 2 | 11 |
| David R. Walt | 2 | 5 |
| Marijn Dekkers | 2 | 4 |
| Babak Yazdani | 1 | 18 |
| John Murphy | 1 | 17 |
| John Connolly | 1 | 14 |
| Danny J. Cunagin | 1 | 10 |
| Troy D. Kopischke | 1 | 10 |
| Ashok Krishnamurthi | 1 | 8 |
| Sonja Hoel Perkins | 1 | 7 |
| Francisco Gimenez | 1 | 7 |
| Chen Yu | 1 | 7 |
| Stanley Lapidus | 1 | 7 |
| Steven Cohen | 1 | 6 |
| Victor Tong | 1 | 6 |
| John M. Connolly | 1 | 6 |
| Douglas Cole | 1 | 5 |
| William Blake | 1 | 5 |
| Craig Parker | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.